[Polycystic ovary syndrome--only relevant in reproductive medicine?]

  • Universitäts Frauenklinik ROR
  • University of Basel ROR
  • Abteilung für gynäkologische Endokrinologie und Reproduktionsmedizin, Universitäts-Frauenklinik, Basel
  • Abteilung für gynäkologische Endokrinologie und Reproduktionsmedizin, Universitäts-Frauenklinik, Basel.

Therapeutische Umschau. Revue Therapeutique, 56(5), 271-275

DOI 10.1024/0040-5930.56.5.271 PMID 10409902

Abstract

The Polycystic Ovary Disease (PCOD) is one of the most common endocrine disorders in women with a prevalence of 5%. Affected women often consult a gynecologist because of menstrual irregularities, fertility problems or problems of androgen excess. However, PCOD is a metabolic disorder affecting multiple organs. Studies suggest that those women are at risk for developing several complications such as type II diabetes mellitus, hypertension, dyslipidemia and myocardial infarction. The risk to develop endometrial carcinoma is also elevated. To give adequate treatment to women with PCOD, an interdisciplinary approach of gynecologists together with endocrinologists specialized in metabolic and nutritional disorders at the University of Basel is presented. The work-up for diagnosis and assessment of risk factors is outlined. Goal of this interdisciplinary approach is an adequate evaluation of affected patients and their long-term follow-up to test if proposed interventions as weight loss, treatment of hyperinsulinemia, regulation of menstrual cycle and others can avoid long-term sequelae.

Topics

polycystic ovary syndrome metabolic disorder multiple organs, PCOS cardiovascular risk type 2 diabetes long-term, PCOS interdisciplinary approach gynecologist endocrinologist, polycystic ovary disease hyperinsulinemia weight loss treatment, PCOS endometrial carcinoma risk factor, PCOS dyslipidemia hypertension myocardial infarction risk, polycystic ovary syndrome beyond reproductive medicine, PCOS menstrual irregularity androgen excess metabolic syndrome, PCOS long-term sequelae prevention interdisciplinary management
PMID 10409902 10409902 DOI 10.1024/0040-5930.56.5.271 10.1024/0040-5930.56.5.271

Cite this article

Heim, S. C., De Geyter, C., Siegrist, W., Bilz, S., & Keller, U. (1999). Polycystic ovary syndrome--only relevant in reproductive medicine?. *Therapeutische Umschau. Revue therapeutique*, *56*(5), 271-275. https://doi.org/10.1024/0040-5930.56.5.271

Related articles